EP 3664852 A1 20200617 - A COMPOSITION FOR ORAL ADMINISTRATION IN THE THERAPEUTIC OR PREVENTIVE TREATMENT OF GASTROESOPHAGEAL REFLUX DISORDERS OR DISEASE
Title (en)
A COMPOSITION FOR ORAL ADMINISTRATION IN THE THERAPEUTIC OR PREVENTIVE TREATMENT OF GASTROESOPHAGEAL REFLUX DISORDERS OR DISEASE
Title (de)
ZUSAMMENSETZUNG ZUR ORALEN VERABREICHUNG BEI DER THERAPEUTISCHEN ODER PRÄVENTIVEN BEHANDLUNG VON GASTROÖSOPHAGEALEM REFLUX
Title (fr)
COMPOSITION POUR ADMINISTRATION ORALE DANS LE TRAITEMENT THÉRAPEUTIQUE OU PRÉVENTIF DE TROUBLES OU DE LA MALADIE DU REFLUX GASTRO-OESOPHAGIEN
Publication
Application
Priority
- IT 201700091733 A 20170808
- IB 2018055854 W 20180803
Abstract (en)
[origin: WO2019030629A1] The present invention relates to a composition for use in a method for treating gastroesophageal reflux disorders or disease, preferably in a method for the symptomatic treatment of gastroesophageal reflux disorders or disease, wherein said composition is for oral use, in any form of administration pharmaceutically acceptable, and comprises a mixture comprising or, alternatively, consisting of an extract of Trigonella foenum graecum and a block copolymer of ethylene oxide and propylene oxide.
IPC 8 full level
A23L 33/105 (2016.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 36/48 (2006.01); A61K 47/10 (2017.01); A61P 1/04 (2006.01)
CPC (source: EP)
A23L 33/105 (2016.07); A61K 9/0053 (2013.01); A61K 9/1641 (2013.01); A61K 9/2031 (2013.01); A61K 36/48 (2013.01); A61K 47/10 (2013.01)
Citation (search report)
See references of WO 2019030629A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019030629 A1 20190214; EP 3664852 A1 20200617; IT 201700091733 A1 20190208
DOCDB simple family (application)
IB 2018055854 W 20180803; EP 18762148 A 20180803; IT 201700091733 A 20170808